Oruka Therapeutics, Inc.

ORKA Healthcare Biotechnology

In the quarter to June 2026, EPS fell 19.6% and free cash flow fell 43.0%, each against the same quarter a year earlier.

71.93 1.94 −2.63%
Market cap
$4.9B
P/E
0.0×
Fwd P/E
—
Dividend yield
0.00%
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
884.56 395.25 343.86 355.16
Total non-current assets
254.84 109.23 144.76 154.09
Total Assets
1,139.39 504.48 488.62 509.25
Total current liabilities
22.97 16.63 15.37 20.97
Total non-current liabilities
1.88 1.13 1.31 1.49
Total liabilities
24.85 17.76 16.69 22.46
Common Equity (Total)
1,111.62 483.79 469.00 483.86
Shareholders Equity (Total)
1,114.55 486.72 471.93 486.79

Show all line items

In millions of $ except per-share values · columns are period end dates